34.59 USD
▲-0.78+3.81%
2026-08-03
市值
$24.88B
市盈率
—
EPS
-0.54
股息率
—
52 周区间
10.90 – 37.00
成交量
5.88M
Beta
1.11
目标价
38.59
52W 低 10.9052W 高 37.00
价格走势
公司简介
Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease; neonatal fragment crystallizable receptor for the treatment of graves’ disease, difficult-to-treat rh...